Rare diseases
Investigational molecules
Locations
Bismarckstrasse 13, Altstadt, 97080 Wuerzburg, Germany
Pentixapharm AG supports clinical research in central nervous system (CNS) lymphoma, with activity centered on CXCR4-targeted imaging and endoradiotherapy for primary and secondary CNS lymphoma. The sponsor’s trial portfolio in this area includes evaluation of PET/CT approaches for lesion detection and therapeutic studies in patients with CXCR4-positive disease.
Clinical interest extends to both diagnostic precision and treatment assessment in lymphoma involving the central nervous system.
Pentixapharm AG runs clinical trials in conditions such as Neoplasm malignant, Marginal zone lymphoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Germany
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
